The term haematological malignancy refers to a collection of heterogeneous neoplasms with significant variation in presentation, prognosis and management. Survival is vastly different between people with early-stage Hodgkin lymphoma versus elderly people diagnosed with acute myeloid leukaemia. Even within a specific disease type, substantial variation exists in treatment and prognosis that is dependent on characteristics of the individual (i.e. age, comorbidities) and the disease (i.e. cytogenetics, method of development)...
- haematological malignancy
- palliative care